These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21975581)

  • 21. The Many Faces of Huntington's Chorea Treatment: The Impact of Sudden Withdrawal of Tiapride after 40 Years of Use and a Systematic Review.
    Feleus S; van Schaijk M; Roos RAC; de Bot ST
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J; Clarence-Smith K
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of huntington disease.
    Videnovic A
    Curr Treat Options Neurol; 2013 Aug; 15(4):424-38. PubMed ID: 23417276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrabenazine is neuroprotective in Huntington's disease mice.
    Wang H; Chen X; Li Y; Tang TS; Bezprozvanny I
    Mol Neurodegener; 2010 Apr; 5():18. PubMed ID: 20420689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR
    Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J
    Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
    Brusa L; Orlacchio A; Moschella V; Iani C; Bernardi G; Mercuri NB
    Mov Disord; 2009 Jan; 24(1):126-9. PubMed ID: 19170197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician perceptions of pharmacologic treatment options for chorea associated with Huntington disease in the United States.
    Sung VW; Iyer RG; Gandhi SK; Shah-Manek B; DiBonaventura M; Abler V; Claassen DO
    Curr Med Res Opin; 2018 Apr; 34(4):643-648. PubMed ID: 29383957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deutetrabenazine for the treatment of Huntington's chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Aug; 18(8):625-631. PubMed ID: 29996061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrabenazine Facilitates Exocytosis by Enhancing Calcium-Induced Calcium Release through Ryanodine Receptors.
    de Pascual R; Álvarez-Ortego N; de Los Ríos C; Jacob-Mazariego G; García AG
    J Pharmacol Exp Ther; 2019 Oct; 371(1):219-230. PubMed ID: 31209099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Lang AE; Marsden CD
    Clin Neuropharmacol; 1982 Dec; 5(4):375-87. PubMed ID: 6130839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].
    Giménez-Roldán S; Mateo D
    Neurologia; 1989 Oct; 4(8):282-7. PubMed ID: 2534679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.
    Armstrong MJ; Miyasaki JM;
    Neurology; 2012 Aug; 79(6):597-603. PubMed ID: 22815556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.
    Shen V; Clarence-Smith K; Hunter C; Jankovic J
    Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 24255799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tetrabenazine on motor function in patients with huntington disease.
    Ferrara JM; Mostile G; Hunter C; Adam OR; Jankovic J
    Neurol Ther; 2012 Dec; 1(1):5. PubMed ID: 26000211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetrabenazine.
    Fasano A; Bentivoglio AR
    Expert Opin Pharmacother; 2009 Dec; 10(17):2883-96. PubMed ID: 19929707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
    Claassen DO; Philbin M; Carroll B
    Expert Opin Pharmacother; 2019 Dec; 20(18):2209-2221. PubMed ID: 31613641
    [No Abstract]   [Full Text] [Related]  

  • 39. Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.
    Heo YA; Scott LJ
    Drugs; 2017 Nov; 77(17):1857-1864. PubMed ID: 29080203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease.
    Claassen DO; Carroll B; De Boer LM; Wu E; Ayyagari R; Gandhi S; Stamler D
    J Clin Mov Disord; 2017; 4():3. PubMed ID: 28265459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.